MedTrace Logo

A Two-way Communication System to Coach Elderly Patients With Heart Failure

NCT03294811 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-05-13

No results posted yet for this study

Summary

This is an open randomized clinical trial with two study arms. One group, receiving usual care for heart failure, will be compared to another group, receiving usual care plus active telemonitoring interference.

When leaving the hospital, the usual care arm receives a document with a predefined medication scheme and advice for the general practitioner (like it is currently done in usual care).

The telemonitoring interference in the other study arm consists of a smartphone application to register medication intake and to transmit the data of an automatic blood pressure device and a balance to a central platform. The goal is to improve medication uptitration (angiotensin-converting-enzyme inhibitor (ACE-I) and bètablockers (BB)) in heart failure patients and to improve medication compliance.

Conditions

Interventions

DEVICE

Telemonitoring

The telemonitoring interference in the telemonitoring arm consists of a smartphone application that helps the patient to take their medication in time and to take their blood pressure and weight on a daily basis in order to improve the medication uptitration and medication compliance.

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • Jessa Hospital

    collaborator OTHER

  • Hasselt University

    lead OTHER

Principal Investigators

  • Vandervoort Pieter, MD, PhD · Ziekenhuis Oost-Limburg

  • Paul Dendale, MD, PhD · Jessa Ziekenhuis, Hasselt, Belgium

  • Jo Ravelingen · Remedus, Aartselaar, Belgium

  • Peter Van Vooren · Fifthplay, Antwerpen, Belgium

  • Valerie Storms, PhD · Mobile Health Unit, Hasselt University, Hasselt, Belgium

  • Lars Grieten, PhD · Mobile Health Unit, Hasselt University, Hasselt, Belgium

  • Christophe Smeets, PhD student · Mobile Health Unit, Hasselt University, Hasselt, Belgium

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-01
Primary Completion
2016-12-15
Completion
2018-04-04

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03294811 on ClinicalTrials.gov